Skip to main content

This job has expired

You will need to login before you can apply for a job.

Intern - Supply Chain Planning

Employer
Regeneron Pharmaceuticals, Inc.
Location
Rensselaer, New York, US
Start date
Nov 28, 2018

Job Details

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases. Project Description . Title . Weighting Resource Requirements for Early Phase Programs Description . The effort required to manage Early Phase/Pre-IND programs varies from program to program. Designations such as Pre-IND/Phase 1/Phase 2, do not provide a full picture of what is required to manage a program. Criteria such as scale up plans, number of cell lines/processes, number of presentations/SKUs, partnerships, projected BLA dates, and total number of clinical studies all contribute to the true amount of effort required to plan a program. New technologies also can create unique resource requirements i.e. iPet, ADC, Comparators . Deliverable . Develop a matrix type evaluation, with weighted criteria, that would essentially "score" a program on the amount of detail/effort that goes into planning the program. The intern would be responsible for developing the final criteria set, with definitions, and weighted importance see Table 1 . With this complete, the sources for data could then be identified, and an initial calculation completed for a select set of programs. Completing the exercise with programs that have obvious differences in difficulty would help to be sure weights of criteria are aligned. At this point, opportunities for automation of data flow to the matrix could be identified. Opportunity . This tool could be used to identify programs that should be transitioned from "cluster" to "cluster". Additionally, this tool could be used in resource planning in regard to individual workloads and future hiring requirements over time, based on the overall portfolio vs project program life cycles . Desired Majors and/or Skills - Industrial Engineering, creativity, diverse skill set. Desired Education Level - Rising Sophomore/Rising Junior. This is an opportunity to join our select team that is already leading the way in the Pharmaceutical/Biotech industry. Apply today and learn more about Regeneron's unwavering commitment to combining good science & good business. To all agencies . Please, no phone calls or emails to any employee of Regeneron about this opening. All resumes submitted by search firms/employment agencies to any employee at Regeneron via-email, the internet or in any form and/or method will be deemed the sole property of Regeneron, unless such search firms/employment agencies were engaged by Regeneron for this position and a valid agreement with Regeneron is in place. In the event a candidate who was submitted outside of the Regeneron agency engagement process is hired, no fee or payment of any kind will be paid. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert